InvestorsHub Logo
Followers 2
Posts 153
Boards Moderated 0
Alias Born 11/13/2016

Re: None

Tuesday, 03/10/2020 5:58:50 PM

Tuesday, March 10, 2020 5:58:50 PM

Post# of 430414
JesseLivermore: This 2014 article says flu “cytokine storm” can be mitigated by drug that activate S1P1 receptors to dampen immune cell over-response. The drug (Ozanimod) was licensed to Receptos, who was bought by Celgene (now BMY), and awaiting FDA appvl for MS. Why not this for c-virus?

https://www.sciencedaily.com/releases/2014/02/140227142250.htm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News